Business · 14/10/2010Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance for Early Clinical Trials with Live Biotherapeutic Products
Summary
The FDA has made available a draft document outlining recommendations for IND sponsors to submit INDs for early clinical trials involving live biotherapeutic products, as announced in September 2010.
Original source language: Federal Register — Health and Human ServicesOpen original release →